Paper18077828
Genetic variations and treatments that affect the lifespan of the NPC1 mouse.
Liu B and 4 others. J Lipid Res, 2008. Cited by 134 papers, by iCite.
Cite this record
ConductScience Library. Genetic variations and treatments that affect the lifespan of the NPC1 mouse. Papers, record 18077828. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18077828
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA-Binding Proteins | Major topic |
| Genetic Variation | Major topic |
| Longevity | Major topic |
| Proteins | Major topic |
| Receptors, Cytoplasmic and Nuclear | Major topic |
| Sialyltransferases | Major topic |
| Animals | |
| Cyclodextrins | |
| Gene Deletion | |
| Intracellular Signaling Peptides and Proteins | |
| Liver X Receptors | |
| Mice | |
| Mice, Knockout | |
| Neurodegenerative Diseases | |
| Niemann-Pick C1 Protein | |
| Niemann-Pick Diseases | |
| Orphan Nuclear Receptors | |
| Pregnanolone | |
| Treatment Outcome |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 HL-09610 | NHLBI NIH HHS | United States | R01HL009610 | PubMed and NIH | NIH RePORTER |
| T32 DK-07745 | NIDDK NIH HHS | United States | T32DK007745 | PubMed and NIH | NIH RePORTER |
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT02912793 | Safety and Efficacy of Intravenous Trappsol Cyclo (HPBCD) in Niemann-Pick Type C Patients | Background | ClinicalTrials.gov | |
| NCT02939547 | Study of the Pharmacokinetics of Trappsol and Effects on Potential Biomarkers of Niemann-Pick C1 (NPC1) | Background | ClinicalTrials.gov |
Cited by92
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 134 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41260183 | Utility of 24(S)-hydroxycholesterol as a proximal biomarker to monitor long-term intrathecal adrabetadex therapy in individuals with Niemann-Pick disease, type C1. | Mol Genet Metab | 2025 | https://conductscience.org/library/papers/41260183 | PubMed |
| 37942865 | Neuro-HIV-New insights into pathogenesis and emerging therapeutic targets. | FASEB J | 2023 | https://conductscience.org/library/papers/37942865 | PubMed |
| 37670901 | Long-term administration of intravenous Trappsol® Cyclo™ (HP-β-CD) results in clinical benefits and stabilization or slowing of disease progression in patients with Niemann-Pick disease type C1: Results of an international 48-week Phase I/II trial. | Mol Genet Metab Rep | 2023 | https://conductscience.org/library/papers/37670901 | PubMed |
| 37567876 | Understanding the phenotypic variability in Niemann-Pick disease type C (NPC): a need for precision medicine. | NPJ Genom Med | 2023 | https://conductscience.org/library/papers/37567876 | PubMed |
| 37407594 | The cholesterol transporter NPC1 is essential for epigenetic regulation and maturation of oligodendrocyte lineage cells. | Nat Commun | 2023 | https://conductscience.org/library/papers/37407594 | PubMed |
| 36979508 | Grafting of Cyclodextrin to Theranostic Nanoparticles Improves Blood-Brain Barrier Model Crossing. | Biomolecules | 2023 | https://conductscience.org/library/papers/36979508 | PubMed |
| 36971991 | Lysosomal cholesterol accumulation is commonly found in most peroxisomal disorders and reversed by 2-hydroxypropyl-β-cyclodextrin. | Sci China Life Sci | 2023 | https://conductscience.org/library/papers/36971991 | PubMed |
| 36721240 | Identification of cerebral spinal fluid protein biomarkers in Niemann-Pick disease, type C1. | Biomark Res | 2023 | https://conductscience.org/library/papers/36721240 | PubMed |
| 36614015 | Organ Weights in NPC1 Mutant Mice Partly Normalized by Various Pharmacological Treatment Approaches. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36614015 | PubMed |
| 36559052 | Cyclodextrins: Only Pharmaceutical Excipients or Full-Fledged Drug Candidates? | Pharmaceutics | 2022 | https://conductscience.org/library/papers/36559052 | PubMed |
| 36542657 | Traits, phylogeny and host cell receptors predict Ebolavirus host status among African mammals. | PLoS Negl Trop Dis | 2022 | https://conductscience.org/library/papers/36542657 | PubMed |
| 35140266 | Correlation of age of onset and clinical severity in Niemann-Pick disease type C1 with lysosomal abnormalities and gene expression. | Sci Rep | 2022 | https://conductscience.org/library/papers/35140266 | PubMed |
| 34445564 | Myelin Defects in Niemann-Pick Type C Disease: Mechanisms and Possible Therapeutic Perspectives. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34445564 | PubMed |
| 34296265 | Transcriptome of HPβCD-treated Niemann-Pick disease type C1 cells highlights GPNMB as a biomarker for therapeutics. | Hum Mol Genet | 2021 | https://conductscience.org/library/papers/34296265 | PubMed |
| 34202978 | Neurodegeneration in Niemann-Pick Type C Disease: An Updated Review on Pharmacological and Non-Pharmacological Approaches to Counteract Brain and Cognitive Impairment. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34202978 | PubMed |
| 34113546 | A phase 1/2 open label nonrandomized clinical trial of intravenous 2-hydroxypropyl-β-cyclodextrin for acute liver disease in infants with Niemann-Pick C1. | Mol Genet Metab Rep | 2021 | https://conductscience.org/library/papers/34113546 | PubMed |
| 33878344 | Lipid-mediated motor-adaptor sequestration impairs axonal lysosome delivery leading to autophagic stress and dystrophy in Niemann-Pick type C. | Dev Cell | 2021 | https://conductscience.org/library/papers/33878344 | PubMed |
| 33802605 | Gender-Specific Effects of Two Treatment Strategies in a Mouse Model of Niemann-Pick Disease Type C1. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33802605 | PubMed |
| 33256121 | Understanding and Treating Niemann-Pick Type C Disease: Models Matter. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33256121 | PubMed |
| 32890578 | Delineation of metabolic responses of Npc1-/-nih mice lacking the cholesterol-esterifying enzyme SOAT2 to acute treatment with 2-hydroxypropyl-β-cyclodextrin. | Steroids | 2020 | https://conductscience.org/library/papers/32890578 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18077828
GET https://conductscience.org/api/papers/v1/18077828/cited_by?page=2